FCGR3A (C-term), 226-254 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-FCGR3A (C-term), 226-254 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | FCGR3A (C-term), 226-254 |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human |
| Isotype | n/a |
| Format | peptide affinity purified |
| Size | 0.08 mL, 0.4 mL |
| Concentration | vial concentration: 0.5 |
| Applications | Western Blot (WB), ELISA (EIA) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | This FCGR3A antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 226-254 amino acids from the C-terminal region of human FCGR3A. This gene encodes a receptor for the Fc portion ofimmunoglobulin G, and it is involved in the removal ofantigen-antibody complexes from the circulation, as well as otherother antibody-dependent responses. This gene (FCGR3A) is highlysimilar to another nearby gene (FCGR3B) located on chromosome 1.The receptor encoded by this gene is expressed on natural killer(NK) cells as an integral membrane glycoprotein anchored through atransmembrane peptide, whereas FCGR3B is expressed onpolymorphonuclear neutrophils (PMN) where the receptor is anchored |
| Immunogen | n/a |
| Other Names | [Low affinity immunoglobulin gamma Fc region receptor III-A; CD16a antigen; Fc-gamma RIII-alpha; Fc-gamma RIII; Fc-gamma RIIIa; FcRIII; FcRIIIa; FcR-10; IgG Fc receptor III-2; CD16a; FCGR3A; CD16A; FCG3; FCGR3; IGFR3] |
| Gene, Accession # | [FCGR3A], Gene ID: 2214, NCBI: NP_000560.5, UniProt: P08637 |
| Catalog # | MBS9215097 |
| Price | $165, $370 |
| Order / More Info | FCGR3A (C-term), 226-254 Antibody from MYBIOSOURCE INC. |
| Product Specific References | Dornan, D., et al. Blood 116(20):4212-4222(2010) Li, S.C., et al. Am. J. Hematol. 85(10):810-812(2010) Iwasaki, M., et al. Breast Cancer Res. Treat. (2010) In press : Qu, Y.H., et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi 18(4):959-962(2010) Sfar, I., et al. Arch Inst Pasteur Tunis 86 (1-4), 51-62 (2009) : |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies